TRU-016 (anti-CD37 protein therapeutic)
16007
Phase 1 small_molecule completed
Quick answer
TRU-016 (anti-CD37 protein therapeutic) for Chronic Lymphocytic Leukemia (CLL) is a Phase 1 program (small_molecule) at Aptevo Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Aptevo Therapeutics
- Indication
- Chronic Lymphocytic Leukemia (CLL)
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed